Peptic ulcer as mediator of the association between risk of gastric cancer and socioeconomic status, tobacco smoking, alcohol drinking and salt intake.

Alcohol Gastric cancer Mediation analysis Peptic ulcer disease Salt Smoking Socioeconomic status

Journal

Journal of epidemiology and community health
ISSN: 1470-2738
Titre abrégé: J Epidemiol Community Health
Pays: England
ID NLM: 7909766

Informations de publication

Date de publication:
13 Jul 2022
Historique:
received: 31 03 2022
accepted: 25 06 2022
entrez: 13 7 2022
pubmed: 14 7 2022
medline: 14 7 2022
Statut: aheadofprint

Résumé

Peptic ulcer disease (PUD) and gastric cancer (GC) are more prevalent in individuals with low socioeconomic status (SES) and share several risk factors. The aim of this study was to investigate the mediating role of PUD in the association between established risk factors and GC. We conducted a pooled analysis of 12 studies from the Stomach Cancer Pooling Project Consortium, including a total of 4877 GC cases and 11 808 controls. We explored the mediating role of PUD in the association between SES, tobacco smoking, heavy alcohol drinking and salt intake, and GC. Also, we assessed the ORs and 95% CIs of the risk factors and both PUD and GC. PUD mediated 36% of the smoking effect mainly among men. Other risk factors were only slightly mediated by PUD (SES, 5.3%; heavy alcohol drinking, 3.3%; and salt intake, 2.5%). No significant difference was found when excluding PUD diagnosed within 2 years from GC. Our study provides innovative information on the mechanism of stomach mucosal damage leading to PUD and GC, with respect to the effect of tobacco smoking in particular.

Sections du résumé

BACKGROUND BACKGROUND
Peptic ulcer disease (PUD) and gastric cancer (GC) are more prevalent in individuals with low socioeconomic status (SES) and share several risk factors. The aim of this study was to investigate the mediating role of PUD in the association between established risk factors and GC.
METHODS METHODS
We conducted a pooled analysis of 12 studies from the Stomach Cancer Pooling Project Consortium, including a total of 4877 GC cases and 11 808 controls. We explored the mediating role of PUD in the association between SES, tobacco smoking, heavy alcohol drinking and salt intake, and GC. Also, we assessed the ORs and 95% CIs of the risk factors and both PUD and GC.
RESULTS RESULTS
PUD mediated 36% of the smoking effect mainly among men. Other risk factors were only slightly mediated by PUD (SES, 5.3%; heavy alcohol drinking, 3.3%; and salt intake, 2.5%). No significant difference was found when excluding PUD diagnosed within 2 years from GC.
CONCLUSIONS CONCLUSIONS
Our study provides innovative information on the mechanism of stomach mucosal damage leading to PUD and GC, with respect to the effect of tobacco smoking in particular.

Identifiants

pubmed: 35831132
pii: jech-2022-219074
doi: 10.1136/jech-2022-219074
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Giulia Collatuzzo (G)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.

Gianfranco Alicandro (G)

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milano, Italy.
Cystic Fibrosis Center, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Paola Bertuccio (P)

Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology "G.A. Maccacaro", Università degli Studi di Milano, Milan, Italy.
Department of Public Health, Experimental and Forensic Medicine, University of Pavia, Pavia, Italy.

Claudio Pelucchi (C)

Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology "G.A. Maccacaro", Università degli Studi di Milano, Milan, Italy.

Rossella Bonzi (R)

Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology "G.A. Maccacaro", Università degli Studi di Milano, Milan, Italy.

Domenico Palli (D)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network, ISPRO, Florence, Italy.

Monica Ferraroni (M)

Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology "G.A. Maccacaro", Università degli Studi di Milano, Milan, Italy.

Weimin Ye (W)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

Amelie Plymoth (A)

Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.

David Zaridze (D)

Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Center, Moscow, Russia.

Dmitry Maximovich (D)

Department of Epidemiology and Prevention, Russian N.N. Blokhin Cancer Research Center, Moscow, Russia.

Nuria Aragones (N)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Cancer Epidemiology Section, Public Health Division, Department of Health of Madrid, Madrid, Spain.

Gemma Castaño-Vinyals (G)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Barcelona Institute for Global Health-ISGlobal, Barcelona, Spain.
IMIM (Hospital del Mar Medical Research Institute), Barcelona, Spain.
Universitat Pompeu Fabra (UPF), Barcelona, Spain.

Jesus Vioque (J)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernandez (ISABIAL-UMH), Alicante, Spain.

Manoli Garcia de la Hera (M)

Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), Madrid, Spain.
Instituto de Investigación Sanitaria y Biomédica de Alicante, Universidad Miguel Hernandez (ISABIAL-UMH), Alicante, Spain.

Zuo-Feng Zhang (ZF)

Department of Epidemiology, UCLA Fielding School of Public Health and Jonsson Comprehensive Cancer Center, Los Angeles, California, USA.

Jinfu Hu (J)

Harbin Medical University, Harbin, People's Republic of China.

Lizbeth Lopez-Carrillo (L)

Mexico National Institute of Public Health, Morelos, Mexico.

Malaquías López-Cervantes (M)

Facultad de Medicina, UNAM. Coyoacán, Mexico.

Michela Dalmartello (M)

Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology "G.A. Maccacaro", Università degli Studi di Milano, Milan, Italy.

Lina Mu (L)

Department of Epidemiology and Environmental Health, School of Public Health and Health Professions, University at Buffalo, Buffalo, NY, USA.

Mary H Ward (MH)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

Charles Rabkin (C)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

Guo-Pei Yu (GP)

Medical Informatics Center, Peking University, Peking, People's Republic of China.

M Constanza Camargo (MC)

Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Rockville, MD, USA.

Maria Paula Curado (MP)

Centro Internacional de Pesquisa, A. C. Camargo Cancer Center, São Paulo, Brazil.

Nuno Lunet (N)

EPIUnit - Instituto de Saúde Pública da Universidade do Porto, Porto, Portugal.
Laboratório para a Investigação Integrativa e Translacional em Saúde Populacional (ITR), Porto, Portugal.
Departamento de Ciências da Saúde Pública e Forenses e Educação Médica, Faculdade de Medicina da Universidade do Porto, Porto, Portugal.

Eva Negri (E)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology "G.A. Maccacaro", Università degli Studi di Milano, Milan, Italy.

Carlo La Vecchia (C)

Department of Clinical Sciences and Community Health, Branch of Medical Statistics, Biometry and Epidemiology "G.A. Maccacaro", Università degli Studi di Milano, Milan, Italy.

Paolo Boffetta (P)

Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy paolo.boffetta@stonybrookmedicine.edu.
Stony Brook Cancer Center, Stony Brook University, Stony Brook, New York, USA.

Classifications MeSH